Visibilización de las estrategias de rebranding y captura corporativa de la salud pública por la industria del cannabis

  1. Manuel Isorna Folgara
  2. Víctor J. Villanueva-Blasco
Journal:
Revista española de drogodependencias

ISSN: 0213-7615

Year of publication: 2022

Issue Title: Abordaje y actualización sobre el consumo de cannabis en la población española

Issue: 47

Pages: 17-36

Type: Article

DIALNET GOOGLE SCHOLAR

More publications in: Revista española de drogodependencias

Abstract

When policies affect commercial determinants of health, such as alcohol, tobacco and cannabis, it is known as corporate capture of public health. The aim of the study was to make visible the strategies promoting cannabis cultivation, consumption and regulation oriented towards industry-friendly regulation, to the detriment of public health. An exploratory qualitative design was followed using a purposive sample from the various information channels used by the cannabis industry. The rebranding and corporate capture strategies found are based on: (a) economic development arguments to justify its expansion and lax regulation; (b) promotion of a positive image of cannabis by associating its use with health and wellbeing purposes; (c) promotion of a more acceptable social image of the consumer, the self-cultivator and even the seller; (d) consumer recruitment and loyalty through products derived from film, television or video games, and especially through influencers; e) advertising and event sponsorship gifts aimed at the “tarjet” of potential consumers; f) the dissemination of fake news suggesting that cannabis cures diseases; and, g) distorting processes affecting cannabis research, when funding comes from the cannabis industry. These findings highlight the cannabis industry’s corporate capture actions aimed at blocking or delaying public health measures that are contrary to its economic interests.

Bibliographic References

  • Abuhasira, R., Shbiro, L. y Landschaft, Y. (2018). Medical use of cannabis and cannabinoids containing products–regulations in Europe and North America. European Journal of Internal Medicine, 49, 2-6. https://doi.org/10.1016/j. ejim.2018.01.001
  • Abu-Sawwa, R., Scutt, B. y Park, Y. (2020). Emerging use of epidiolex (cannabidiol) in epilepsy. The Journal of Pediatric Pharmacology and Therapeutics, 25(6), 485-499. https://doi.org/10.5863/1551-6776- 25.6.485
  • Acheson, D. (1988). Public health in England: the report of the Committee of Inquiry into the Future Development of the Public Health Function. The Stationary Office, 23-34.
  • Adams, P. J. (2007). Assessing whether to receive funding support from tobacco, alcohol, gambling and other dangerous consumption industries. Addiction, 102(7), 1027-1033. https://doi. org/10.1111/j.1360-0443.2007.01829.x Adams, P. J., Rychert, M. y Wilkins, C. (2021). Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries. Addic- tion, 116(11), 2839-2946. https://doi. org/10.1111/add.15483
  • Andréasson, S. y McCambridge, J. (2016). Alcohol researchers should not accept funding from the alcohol industry: perspectives from brief interventions research. Journal of studies on alcohol and drugs, 77(4), 537-540. https://doi. org/10.15288/jsad.2016.77.537
  • Austen, I. (2017). Ready or Not, Recreational Marijuana Use Is Coming to Canada. The New York Times. https://www.nytimes. com/2017/11/04/world/canada/canada-marijuana-legal-justin-trudeau.html
  • Ayers, J. W., Caputi, T. L. y Leas, E. C. (2019). The need for federal regulation of marijuana marketing. JAMA, 321(22), 2163-2164. https://doi.org/10.1001/jama.2019.4432
  • Barrientos-Gutiérrez, T., Barrientos-Gutiérrez, I., Reynales-Shigematsu, L. M., Thrasher, J. F. y Lazcano-Ponce, E. (2012). Aiming for the adolescent market: internet and video games, the new strategies of the tobacco industry. Salud pública de Mexico, 54(3), 303-314.
  • Barry, R. A. y Glantz, S. A. (2018). Marijuana regulatory frameworks in four us states: an analysis against a public health standard. American journal of public health, 108(7), 914-923. https://doi. org/10.2105/AJPH.2018.304401.
  • Becoña, E. (2021). La Prevención Ambiental en el Consumo de Drogas. ¿Qué medidas podemos aplicar? Ministerio de Sanidad. Delegación del Gobierno para el Plan Nacional sobre Drogas, 272 p.
  • Brownell, K. D. y Warner, K. E. (2009). The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? The Milbank Quarterly, 87(1), 259-294.
  • Burillo-Putze, G., Hernández-Ramos, I. y Isorna-Folgar, M. (2021). Hiperemesis por cannabis vs vómitos cíclicos. Adicciones, 33(4), 377-378.
  • Calafat, A., Juan, M., Becoña, E., Fernández, C., Gil, E. y Llopis, J. (2000). Estrategias y organización de la cultura pro-cannabis. Adicciones, 12(5), 231-273. https:// doi.org/10.20882/adicciones.683
  • Caulkins, J. (2016). The real dangers of marijuana. National Affairs, (Winter 2016) https://www.nationalaffairs.com/publications/detail/the-real-dangers-ofmarijuana
  • Chapman, S. y Shatenstein, S. (2001). The ethics of the cash register: taking tobacco research dollars. Tobacco Control, 10(1), 1-2. http://doi.org/10.1136/ tc.10.1.1
  • Chung, C., Salottolo, K., Tanner, A., Carrick, M. M., Madayag, R., Berg, G., Lieser, M. y Bar-Or, D. (2019). The impact of recreational marijuana commercialization on traumatic injury. Injury Epidemiology, 6(1), 1-8. https://doi.org/10.1186/s40621- 019-0180-4
  • Civantos, D. (30 de agosto de 2018). Los influencers más destacados del negocio de la marihuana. Recuperado el 10 julio de 2022 de https://www.dinafem.org/es/ blog/influencers-destacados-negociomarihuana/
  • Davies, R. (2 de marzo de 2019). Sweet smell of success? Big businesses bet on a marijuana boom. The Guardian. https:// www.theguardian.com/business/2019/ mar/02/legal-medicinal-recreationalcannabis-industry-investors
  • Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., Hall, W. D.,… Engell, R. E. (2013). Global burden of disease attributable to illicit drug use and dependence: Findings from the global burden of disease study 2010. The Lancet, 382, 1564-1574. https://doi. org/10.1016/S0140-6736(13)61530-5
  • Di Forti, M., Sallis, H., Allegri, F., Trotta, A., Ferraro, L., Stilo, S. A., Marconi, A., La Cascia, C., Reis Marques, T., Pariante, C., Dazzan, P., Mondelli, V., Paparelli, A., Kolliakou, A., Prata, D., Gaughran, F., David, A. S., Morgan, C., Stahl, D., Khondoker, M., … Murray, R. M. (2014). Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophrenia bulletin, 40(6), 1509–1517. https://doi.org/10.1093/schbul/sbt181
  • Evans, E. A., Goldwater, E., Stanek, E. J., Brierley-Bowers, P., Buchanan, D. & Whitehill, J. M. (2020). Prevalence and correlates of cannabis use in Massachusetts after cannabis legalization and before retail sales. Journal of psychoactive drugs, 53(2), 158–167. https://doi.org/10.1080/027 91072.2020.1850945
  • Fallin, A., Grana, R. y Glantz, S. A. (2014). ‘To quarterback behind the scenes, thirdparty efforts’: the tobacco industry and the Tea Party. Tobacco Control, 23(4), 322-331. https://doi.org/10.1136/tobaccocontrol-2012-050815
  • Felson, J., Adamczyk, A. y Thomas, C. (2019). How and why have attitudes about cannabis legalization changed so much? Social Science Research, 78, 12-27. https://doi. org/10.1016/j. ssresearch.2018.12.011
  • Gamella, J. F. y Jiménez, M. L. (2004). La cultura cannábica en España: La construcción de una tradición ultramoderna. Monografías humanitas, 5, 23-54.
  • Gilmore, A. B., Savell, E. y Collin, J. (2011). Public health, corporations and the New Responsibility Deal: promoting partner ships with vectors of disease. Journal of Public Health, 33(1), 2-4. https://doi. org/10.1093/pubmed/fdr008
  • Government of Canada. (2021). Canadian cannabis survey 2020: Summary. Recuperado de https://www.canada.ca/en/ health-canada/services/drugs-medication/cannabis/research-data/canadiancannabis-survey-2020-summary.html#a2
  • Hall, W. y Lynskey, M. (2020). Assessing the public health impacts of legalizing recreational cannabis use: the US experience. World Psychiatry, 19(2), 179-186. https://doi.org/10.1002/wps.20735
  • Hall, W., Stjepanović, D., Caulkins, J., Lynskey, M., Leung, J., Campbell, G. y Degenhardt, L. (2019). Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. The Lancet, 394(10208), 1580-1590. https://doi. org/10.1016/S0140-6736(19)31789-1
  • Hernández-Aguado, I. y Chilet-Rosell, E. (2019). Investigación en salud pública: independencia y libertad académica. Revista De Bioética Y Derecho, (45), 59-71.
  • Hew, J. J. (2017). Hall of fame for mobile commerce and its applications: a bibliometric evaluation of a decade and a half (2000–2015). Telematics and Informatics, 34(1), 43-66.
  • Hindley, G., Beck, K., Borgan, F., Ginestet, C. E., McCutcheon, R., Kleinloog, D., ... y Howes, O. D. (2020). Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The Lancet Psychiatry, 7(4), 344-353.
  • Isorna, M., Burillo, G. y Villanueva, V.J. (2022a). Captura corporativa, fake news pro-cannabis y posición de los consumidores ante su regulación. Global Health Promotion, 17579759221107604.
  • Isorna, M., Cruz-Amorós, E. y Villanueva, V. J. (2020b). La violencia tabáquica: papel de los medios audiovisuales, influencers y las think tanks. Revista Española de Drogodependendencias, 45(1), 101-110.
  • Isorna, M., Figueiredo, M. J. y Gutiérrez, L. (2019). Cómo pueden las fake news o las falsas creencias contribuir al consumo de cannabis. En M. Isorna y A. Rial (Coords.), El consumo de cannabis y sus derivados: Mitos, posverdades y desafíos (pp. 161-176). Dykinson.
  • Isorna, M., Pascual, F., Aso, E. y Arias, F. (2022b). Impacto de la legalización del consumo recreativo del cannabis. Adicciones (en prensa). https://doi. org/10.20882/adicciones.1694
  • Iversen, L. L. (2001). The science of marijuana. Oxford University Press.
  • Kickbusch, I., Allen, L. y Franz, C. (2016). The commercial determinants of health. The Lancet Global Health, 4(12), e895-e896.
  • Lyness, S. M. y McCambridge, J. (2014). The alcohol industry, charities and policy influence in the UK. The European Journal of Public Health, 24(4), 557-561. https:// doi.org/10.1093/eurpub/cku076
  • Marijuana Business Daily (2020, 1 Mayo). Constellation ups stake in marijuana producer Canopy Growth to 38%. https:// mjbizdaily.com/constellationups-stakein-canopygrowth-to-38/
  • Matthews, P. (2002). La cultura del cannabis. Ed. Alianza.
  • McCambridge, J., Hawkins, B. y Holden, C. (2014). Vested interests in addiction research and policy. The challenge corporate lobbying poses to reducing society’s alcohol problems: Insights from UK evidence on minimum unit pri cing. Addiction, 109, 199–205. https:// doi.org/10.1111/add.12380
  • McKee, M. y Stuckler, D. (2018). Revisiting the corporate and commercial determinants of health. American Journal of Public Health, 108(9), 1167-1170.
  • Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S., … Moffitt, T. E. (2012). Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the Nacional Academy of Sciences of the United States of America, 109, E2657-E2664. https://doi:10.1073/pnas.1206820109
  • Millar, J. S. (2013). The corporate determinants of health: how big business affects our health, and the need for government action! Canadian Journal of Public Health, 104(4), e327-e329.
  • Mindell, J. S., Reynolds, L., Cohen, D. L. y McKee, M. (2012). All in this together: the corporate capture of public health. Bmj, 345, e8082.
  • Miroff, N. (2017). In Uruguay’s marijuana experiment, the government is your pot dealer. https://www.washingtonpost. com/world/the_americas/in-uruguaysmarijuana-experiment-the-governmentis-your-pot-dealer/2017/07/07/6212 360c-5a88-11e7-aa69-3964a7d55207_ story.html?utm_term=.870987e95d47
  • Mitchell, G., Lesch, M. y McCambridge, J. (2020). Alcohol industry involvement in the moderate alcohol and cardiovascular health trial. American Journal of Public Health, 110(4), 485-488.
  • Morell, M. E., Martínez, C. y Quintana, J. L. (2009). Disease mongering, el lucrativo negocio de la promoción de enfermedades. Pediatría Atención Primaria, 11(43), 491-512.
  • National Academies of Sciences, Engineering and Medicine. (2017). The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. National Academies Press.
  • Noticias de la UBC. (2018, 23/11). Professor of Cannabis Science announced to research the role of cannabis in opioid overdose treatment . https://news.ubc. ca/2018/11/23/professor-of-cannabisscience-announced-to-research-the-role-ofcannabis-in-opioid-overdose-treatment/
  • Observatorio europeo del consumo y cultivo de cannabis. Alianzas y redes. https://observatoriocannabis.com/
  • OECD (2017). Preventing Policy Capture: Integrity in Public Decision Making. OECD Public Governance Reviews. OECD Publishing.
  • Oreja-Guevara, C., Montalban, X., de Andrés, C., Casanova-Estruch, B., MuñozGarcía, D., García, I. y Fernández, Ó. (2013). Documento de consenso sobre la espasticidad en pacientes con esclerosis múltiple. Rev Neurol, 57(8), 359-373.
  • Osakwe, O. (2016). Pharmaceutical regulation: the role of government in the business of drug discovery. Academic Press.
  • Pascual, F., Isorna, M., Carvalho, N., Carvalho, F. y Arias, F. (2020). Cannabis terapéutico y COVID-19: entre el oportunismo y la infoxicación. Adicciones, 32(3), 167-172. https://doi.org/10.20882/ adicciones.32.3
  • Policy Surveillance Program Staff (2021). Recreational Marijuana Laws. http://lawatlas. org/datasets/recreational-marijuana-laws
  • Roberts, B. A. (2019). Legalized cannabis in Colorado emergency departments: A cautionary review of negative health and safety effects. Western Journal of Emergency Medicine, 20, 557. https://doi. org/10.5811/westjem.2019.4.39935
  • Royo-Bordonada, M. (2019). Captura corporativa de la salud pública. Revista De Bioética Y Derecho, (45), 25-41.
  • RTTNews (2019, Marz 8,). Altria group completes acquisition of 45% stake in Cronos Group. Markets Insider. https://markets. businessinsider.com/news/stocks/altriagroup-completes-acquisition-of-45-stakein-cronos-group-quick-facts-1028015633
  • Ruíz de Gauna, P. (2016). La venta legal de marihuana: el mejor ejemplo de rebranding. Recuperado de https://www.marketingdirecto.com/marketing-general/ tendencias/la-venta-legal-de-marihuanael-mejor-ejemplo-de-rebranding
  • Russo, E. y Guy, G. W. (2006). A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Medical Hypotheses, 66(2), 234-246. https://doi.org/10.1016/j. mehy.2005.08.026
  • Rychert, M. y Wilkins, C. (2021). Why did New Zealand’s referendum to legalise recreational cannabis fail? Drug and Alcohol Review, 40(6), 877-881.
  • Sepúlveda, J. y Murray, C. (2014). The state of global health in 2014. Science, 345(6202), 1275- 1278. https://doi:10.1126/science.1257099
  • Shi, S., Brant, A. R., Sabolch, A., y Pollom, E. (2019). False news of a cannabis cancer cure. Cureus, 11(1). https://doi. org/10.7759/cureus.3918
  • Smith, A. (2018). La industria de la marihuana legal en Estados Unidos está en auge. https:// cnnespanol.cnn.com/2018/02/01/ marihuana-legal-estados-unidos-industriaauge/
  • Snowdon, C. (2018). Joint venture: estimating the size and potential of the UK cannabis market. Institute of Economic Affairs (IEA).
  • Soneji, S., Yang, J., Knutzen, K. E., Moran, M. B., Tan, A. S., Sargent, J. y Choi, K. (2018). Online tobacco marketing and subsequent tobacco use. Pediatrics, 141(2). https:// doi.org/10.1542/peds.2017-2927
  • Spillane, T. E., Wong, B. A. y Giovenco, D. P. (2021). Content analysis of Instagram posts by leading cannabis vaporizer brands. Drug and Alcohol Dependence, 218, 108353. https://doi. org/10.1016/j.drugalcdep.2020.108353
  • Stanaway, J. D., Afshin, A., Gakidou, E., Lim, S. S., Abate, D., Abate, K. H., Abbafati, C., Abbasi, N., Abbastabar, H. y Abd-Allah, F. (2018). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1923-1994. https://doi. org/10.1016/S0140-6736(18)32225-6
  • The NORML Foundation (2021). A voice for responsible marijuana consumers. Recuperado de https://norml.org/about-norml/
  • Unger, J. B. y Bartsch, L. (2018). Exposure to tobacco websites: associations with cigarette and e-cigarette use and susceptibility among adolescents. Addictive behaviors, 78, 120-123. https://doi. org/10.1016/j.addbeh.2017.11.012
  • Van der Eijk, Y., Bero, L. A. y Malone, R. E. (2019). Philip Morris International-funded ‘Foundation for a Smoke-Free World’: analysing its claims of independence. Tobacco control, 28(6), 712-718. http://doi. org/10.1136/tobaccocontrol-2018-054278
  • Vemuri, V. K. & Makriyannis, A. (2015). Medicinal chemistry of cannabinoids. Clinical Pharmacology & Therapeutics, 97(6), 553- 558.
  • Villalbí, J. R. (2017). Licencia para matar: una historia del tabaco en España. Gaceta Sanitaria, 31(1), 74.
  • Wang, G., Davies, S., Halmo, L., Sass, A. y Mistry, R. (2018). Impact of marijuana legalization in Colorado on adolescent emergency and urgent care visits. Journal of Adolescent Health, 63, 239-241. https://doi. org/10.1016/j.jadohealth.2017.12.010
  • White, J. y Bero, L. A. (2010). Corporate manipulation of research: strategies are similar across five industries. Stan.L.& Pol’Y Rev., 21, 105.
  • Wiist, W. H. (2011). The corporate play book, health, and democracy: the snack food and beverage industry’s tactics in context. En D. Stuckler y K. Siegel (Eds.), Sick Societies: Responding to the Global Challenge of Chronic Disease (pp. 204–21). Oxford University Press.
  • World Health Organization. (2016). Health and Social Effects of Nonmedical Cannabis Use (The). World Health Organization. https://www.who.int/substance_abuse/publications/msbcannabis.pdf
  • Yeoh, P. (2020). Legal challenges for the cannabis industry. Journal of Money Laundering Control, 23(2), 327-340. https://doi. org/10.1108/JMLC-06-2019-0049
Data source: Dialnet